Ginkgo Bioworks Holdings, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -119.86M-126.72M-1836.64M-2106.37M-892.87M-547.03M
Depreciation and Depletion 9.60M12.60M26.90M36.90M54.80M45.00M
Share-based Compensation 0.77M0.48M1,606.02M1,930.64M229.88M112.34M
Deferred Taxes -14.61M-0.80M-0.94M
Gains from Sales and Divestitures 85.83M136.18M
Gains from Investment Securities 2.36M33.35M22.45M10.50M-5.17M-5.70M
Asset Writedowns and Impairment 121.40M4.82M
Cash from Restructuring 4.82M
Non-cash Items 185.62M9.54M
Change in Working Capital 10.79M
Change in Receivables 1.84M14.23M114.09M-55.02M-50.07M4.72M
Change in Inventory 2.74M0.63M-0.16M
Change in Account Payables 0.66M7.02M-2.25M-10.84M-1.18M4.77M
Change in Accured Expenses 4.17M8.66M44.80M-39.64M16.90M-40.44M
Other Working Capital Changes 4.88M-19.42M18.62M-36.42M-35.92M-68.64M
Cash from Operations -44.66M-135.83M-253.82M-252.20M-295.50M-319.58M
Depreciation, Depletion & Amortization
Amortization of Goodwill 47.90M
Amortizatization of Intangibles 19.08M28.31M28.09M
Depreciation & Amortization (CF) 10.76M13.86M29.08M42.55M70.51M63.02M
Investing Activities
Capital Expenditures 22.22M57.82M56.52M52.27M40.80M62.54M
Sales of Property, Plant and Equipment 4.43M0.65M
Acquisitions 12.04M-82.37M5.40M
Change in Acquisitions & Divestments 0.30M10.00M4.52M
Cash from Investing Activities -74.60M-67.12M-73.26M-67.39M-80.69M-62.24M
Financing Activities
Other financing activities 59.93M
Cash from Financing Activities 410.38M90.32M1,534.14M95.34M-3.22M-1.74M
Additional items
Exchange Rate Effect -0.02M0.91M-0.59M-0.28M
Change in Cash 291.12M-112.63M1,207.05M-223.35M-380.00M-383.84M
Beginning Cash Balance 204.17M493.43M342.95M1,539.14M1,324.07M945.41M
Free Cash Flow -66.88M-193.65M-310.34M-304.47M-336.30M-382.13M
Net Cash Flow 291.12M-112.63M1,207.07M-224.25M-379.41M-383.56M